Impaired neutralizing antibodies and preserved cellular immunogenicity against SARS-CoV-2 in systemic autoimmune rheumatic diseases

Impaired neutralizing antibodies and preserved cellular immunogenicity against SARS-CoV-2 in systemic autoimmune rheumatic diseases

Abstract Reports on vaccine immunogenicity in patients with systemic autoimmune rheumatic diseases (SARDs) have been inconclusive. Here, we report the immunogenicity of heterologous prime-boost with an inactivated vaccine followed by an adenoviral vector vaccine in patients with SARDs using anti-RBD...

Full description

Bibliographic Details
Main Authors:	Porntip Intapiboon, Parichat Uae-areewongsa, Jomkwan Ongarj, Ratchanon Sophonmanee, Purilap Seepathomnarong, Bunya Seeyankem, Smonrapat Surasombatpattana, Nawamin Pinpathomrat
Format:	Article
Language:	English
Published:	Nature Portfolio 2022-11-01
Series:	npj Vaccines
Online Access:	https://doi.org/10.1038/s41541-022-00568-9

Similar Items

Regulatory T Cells Decreased during Recovery from Mild COVID-19
by: Purilap Seepathomnarong, et al.
Published: (2022-07-01)

T-Cell Responses Induced by an Intradermal BNT162b2 mRNA Vaccine Booster Following Primary Vaccination with Inactivated SARS-CoV-2 Vaccine
by: Ratchanon Sophonmanee, et al.
Published: (2022-09-01)

Intradermal Fractional ChAdOx1 nCoV-19 Booster Vaccine Induces Memory T Cells: A Follow-Up Study
by: Ratchanon Sophonmanee, et al.
Published: (2024-01-01)

Humoral Immunogenicity of mRNA Booster Vaccination after Heterologous CoronaVac-ChAdOx1 nCoV-19 or Homologous ChAdOx1 nCoV-19 Vaccination in Patients with Autoimmune Rheumatic Diseases: A Preliminary Report
by: Porntip Intapiboon, et al.
Published: (2023-02-01)

Heterologous COVID-19 Vaccination and Booster with mRNA Vaccine Provide Enhanced Immune Response in Patients with Cirrhosis: A Prospective Observational Study
by: Pimsiri Sripongpun, et al.
Published: (2023-09-01)

Immunogenicity and safety of an intradermal ChAdOx1 nCoV-19 boost in a healthy population
by: Nawamin Pinpathomrat, et al.
Published: (2022-05-01)

Author Correction: Immunogenicity and safety of an intradermal ChAdOx1 nCoV-19 boost in a healthy population
by: Nawamin Pinpathomrat, et al.
Published: (2022-09-01)

Immunogenicity and Safety of an Intradermal BNT162b2 mRNA Vaccine Booster after Two Doses of Inactivated SARS-CoV-2 Vaccine in Healthy Population
by: Porntip Intapiboon, et al.
Published: (2021-11-01)

Evaluation of immune profiles associated with control of mycobacterial growth in systemic lupus erythematosus (SLE) patients
by: Ongarj, J, et al.
Published: (2024)

Immunogenicity of inactivated COVID-19 vaccine in patients with autoimmune inflammatory rheumatic diseases
by: Yi-Qing Zheng, et al.
Published: (2022-10-01)

Characteristics, Outcomes, and Factors Affecting Mortality in Hospitalized Patients with CAP Due to Different Variants of SARS-CoV-2 and Non-COVID-19 CAP
by: Nonthanat Tongsengkee, et al.
Published: (2023-02-01)

Immunogenicity and safety of primary fractional-dose yellow fever vaccine in autoimmune rheumatic diseases.
by: Adriana Coracini Tonacio, et al.
Published: (2021-11-01)

Erythematous auricular papules in the fatal cases of anti-MDA5 antibody-positive interstitial lung disease
by: Porntip Intapiboon, et al.
Published: (2020-01-01)

Yellow fever vaccination in Brazil: Short-term safety and immunogenicity in juvenile autoimmune rheumatic diseases
by: Nádia Emi Aikawa, et al.
Published: (2022-04-01)

Evaluation of the immunogenicity of a promising vaccine regimen to identify immune correlates of protection
by: Pinpathomrat, N
Published: (2018)

Curcumin in Autoimmune and Rheumatic Diseases
by: Melissa Yang, et al.
Published: (2019-05-01)

Neopterin in Autoimmune Rheumatic Diseases
by: Nassonov Eugeney L., et al.
Published: (1999-08-01)

Autoimmune polyendocrine syndromes associated with autoimmune rheumatic diseases
by: Katarzyna Jankowska, et al.
Published: (2023-08-01)

LSO-025 Comparison between add-on pulse methylprednisolone versus medium to high dose glucocorticoids alone in Thai patients with proliferative lupus nephritis receiving monthly pulse intravenous cyclophosphamide
by: Thananant Trongkamolthum, et al.
Published: (2023-07-01)

Immunogenicity decay and case incidence six months post Sinovac-CoronaVac vaccine in autoimmune rheumatic diseases patients
by: Clovis A. Silva, et al.
Published: (2022-10-01)

Hydroxychloroquine in rheumatic autoimmune disorders and beyond
by: Eliise Laura Nirk, et al.
Published: (2020-08-01)

Vitamin D and Autoimmune Rheumatic Diseases
by: Lambros Athanassiou, et al.
Published: (2023-04-01)

Vaccinations in autoimmune inflammatory rheumatic diseases
by: Leszek Szenborn
Published: (2016-12-01)

MicroRNAs in autoimmune rheumatic diseases
by: G.D. Sebastiani, et al.
Published: (2012-03-01)

Pulmonary hypertension in autoimmune rheumatic diseases
by: L. Massironi, et al.
Published: (2011-09-01)

Cognitive dysfunction in autoimmune rheumatic diseases
by: Csaba Oláh, et al.
Published: (2020-04-01)

Targeting Syk in autoimmune rheumatic diseases
by: GUO-MIN eDENG, et al.
Published: (2016-03-01)

Autoimmune Rheumatic Diseases and Vascular Function: The Concept of Autoimmune Atherosclerosis
by: Ahmed M. Hedar, et al.
Published: (2021-09-01)

Survey on neutralizing antibodies against Zika virus eighteen months post-outbreak in two southern Thailand communities
by: Theerut Densathaporn, et al.
Published: (2020-12-01)

Immunogenicity and safety of the BBIBP‐CorV vaccine in patients with autoimmune inflammatory rheumatic diseases undergoing immunosuppressive therapy in a monocentric cohort
by: Batool Zamani, et al.
Published: (2023-05-01)

Mining the proteome associated with rheumatic and autoimmune diseases
by: Ruiz-Romero, C, et al.
Published: (2019)

Arrhythmias and Conduction Disturbances in Autoimmune Rheumatic Disorders
by: Sotiris C Plastiras, et al.
Published: (2021-01-01)

Adiponectin Deregulation in Systemic Autoimmune Rheumatic Diseases
by: Neža Brezovec, et al.
Published: (2021-04-01)

Macrophage Dysfunction in Autoimmune Rheumatic Diseases and Atherosclerosis
by: Elena V. Gerasimova, et al.
Published: (2022-04-01)

AUTOIMMUNE RHEUMATIC DISEASES: RESULTS AND PROSPECTS FOR RESEARCHES
by: E. L. Nasonov, et al.
Published: (2015-09-01)

THE MAIN MARKERS OF AUTOIMMUNE RHEUMATIC DISEASES AND THEIR INTERPRETATION
by: A. S. Burlakova, et al.
Published: (2016-10-01)

Defensins: Potential Effectors in Autoimmune Rheumatic Disorders
by: Stefan Vordenbäumen, et al.
Published: (2011-08-01)

Genes, autoimmunity and pathogenesis of rheumatic heart disease
by: Guilherme L, et al.
Published: (2011-01-01)

Anti-inflammatory drugs and immunogenicity of vaccines in patients with rheumatic diseases
by: B. S. Belov, et al.
Published: (2021-12-01)

Value of immunogenicity in the TNF-α inhibitor treatment of rheumatic diseases
by: N. V. Chichasova
Published: (2016-01-01)